Delayed Anti-Nogo-A Antibody Application after Spinal Cord Injury Shows Progressive Loss of Responsiveness
- 10 February 2012
- journal article
- research article
- Published by SAGE Publications in Journal of Neurotrauma
- Vol. 29 (3) , 567-578
Abstract
Blocking the function of the myelin protein Nogo-A or its signaling pathway is a promising method to overcome an important neurite growth inhibitory factor of the adult central nervous system (CNS), and to enhance axonal regeneration and plasticity after brain or spinal cord injuries. Several studies have shown increased axonal regeneration and enhanced compensatory sprouting, along with substantially improved functional recovery after treatment with anti-Nogo-A antibodies, Nogo-receptor antagonists, or inhibition of the downstream mediator RhoA/ROCK in adult rodents. Proof-of-concept studies in spinal cord-injured macaque monkeys with anti-Nogo-A antibodies have replicated these findings; recently, clinical trials in spinal cord-injured patients have begun. However, the optimal time window for successful Nogo-A function blocking treatments has not yet been determined. We studied the effect of acute as well as 1- or 2-weeks delayed intrathecal anti-Nogo-A antibody infusions on the regeneration of corticospinal tract (CST) axons and the recovery of motor function after large but anatomically incomplete thoracic spinal cord injuries in adult rats. We found that lesioned CST fibers regenerated over several millimeters after acute or 1-week-delayed treatments, but not when the antibody treatment was started with a delay of 2 weeks. Swimming and narrow beam crossing recovered well in rats treated acutely or with a 1-week delay with anti-Nogo-A antibodies, but not in the 2-week-delayed group. These results show that the time frame for treatment of spinal cord lesions with anti-Nogo-A antibodies is restricted to less than 2 weeks in adult rodents.Keywords
This publication has 49 references indexed in Scilit:
- MAG and OMgp Synergize with Nogo-A to Restrict Axonal Growth and Neurological Recovery after Spinal Cord TraumaJournal of Neuroscience, 2010
- Molecular mechanisms of axon guidance in the developing corticospinal tractProgress in Neurobiology, 2008
- The role of extracellular matrix in CNS regenerationCurrent Opinion in Neurobiology, 2007
- The Nogo–Nogo Receptor Pathway Limits a Spectrum of Adult CNS Axonal GrowthJournal of Neuroscience, 2006
- Nogo-A-Deficient Mice Reveal Strain-Dependent Differences in Axonal RegenerationJournal of Neuroscience, 2006
- Long‐term changes in the molecular composition of the glial scar and progressive increase of serotoninergic fibre sprouting after hemisection of the mouse spinal cordEuropean Journal of Neuroscience, 2004
- Behavioral Testing After Spinal Cord Injury: Congruities, Complexities, and ControversiesJournal of Neurotrauma, 2004
- Long-Lasting Sprouting and Gene Expression Changes Induced by the Monoclonal Antibody IN-1 in the Adult Spinal CordJournal of Neuroscience, 2002
- A Sensitive and Reliable Locomotor Rating Scale for Open Field Testing in RatsJournal of Neurotrauma, 1995
- Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using specific monoclonal antibodyCell, 1984